Nuak Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.15 M
- Company Age 49 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.98 M
- Revenue Growth 10.15%
- Profit Growth -35.34%
- Ebitda -4.23%
- Net Worth 7.24%
- Total Assets 15.59%
About Nuak Laboratories
Nuak Laboratories Pvt Ltd (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 May 1975 and has a history of 49 years and nine months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹0.98 M.
Deba Sikdar, Shyamali Sikdar, and Debayan Sikdar serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24246WB1975PTC030003
-
Company No.
030003
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 May 1975
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Nuak Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deba Sikdar
|
Director | 11-Jul-2008 | Current |
|
Shyamali Sikdar
|
Director | 11-Jul-2008 | Current |
|
Debayan Sikdar
|
Director | 22-Jun-2022 | Current |
Financial Performance of Nuak Laboratories.
Nuak Laboratories Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 10.15% increase. The company also saw a substantial fall in profitability, with a 35.34% decrease in profit. The company's net worth moved up by a moderate rise of 7.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuak Laboratories?
In 2022, Nuak Laboratories had a public holding of 1.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.98 M
₹0
Charges Breakdown by Lending Institutions
- United Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 2012 | United Bank Of India | ₹0.98 M | Open |
How Many Employees Work at Nuak Laboratories?
Unlock and access historical data on people associated with Nuak Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuak Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuak Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
